These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35233116)

  • 1. Is malaria immunity a possible protection against severe symptoms and outcomes of COVID-19?
    Orish VN; Boakye-Yiadom E; Ansah EK; Alhassan RK; Duedu K; Awuku YA; Owusu-Agyei S; Gyapong JO
    Ghana Med J; 2021 Jun; 55(2 Suppl):56-63. PubMed ID: 35233116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and characteristics of malaria among COVID-19 individuals: A systematic review, meta-analysis, and analysis of case reports.
    Wilairatana P; Masangkay FR; Kotepui KU; Milanez GJ; Kotepui M
    PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009766. PubMed ID: 34597315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the COVID-19 Duration on Neglected Parasitic Diseases.
    Ulusan Bağcı Ö
    Turkiye Parazitol Derg; 2021 Dec; 45(4):317-325. PubMed ID: 34889201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malaria and the incidence of COVID-19 in Africa: an ecological study.
    Habibzadeh F
    BMC Infect Dis; 2023 Feb; 23(1):66. PubMed ID: 36737728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low incidence of COVID-19 case severity and mortality in Africa; Could malaria co-infection provide the missing link?
    Osei SA; Biney RP; Anning AS; Nortey LN; Ghartey-Kwansah G
    BMC Infect Dis; 2022 Jan; 22(1):78. PubMed ID: 35065613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could "trained immunity" be induced by live attenuated vaccines protect against COVID-19? Review of available evidence.
    Alsulaiman JW; Khasawneh AI; Kheirallah KA
    J Infect Dev Ctries; 2020 Sep; 14(9):957-962. PubMed ID: 33031080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 and the impact on malaria.
    Chiodini J
    Travel Med Infect Dis; 2020; 35():101758. PubMed ID: 32479815
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of Covid-19 on malaria services in three high endemic districts in Rwanda: a mixed-method study.
    Hakizimana D; Ntizimira C; Mbituyumuremyi A; Hakizimana E; Mahmoud H; Birindabagabo P; Musanabaganwa C; Gashumba D
    Malar J; 2022 Feb; 21(1):48. PubMed ID: 35164781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 in malaria-endemic regions: potential consequences for malaria intervention coverage, morbidity, and mortality.
    Teboh-Ewungkem MI; Ngwa GA
    Lancet Infect Dis; 2021 Jan; 21(1):5-6. PubMed ID: 32971007
    [No Abstract]   [Full Text] [Related]  

  • 10. Indirect effects of the COVID-19 pandemic on malaria intervention coverage, morbidity, and mortality in Africa: a geospatial modelling analysis.
    Weiss DJ; Bertozzi-Villa A; Rumisha SF; Amratia P; Arambepola R; Battle KE; Cameron E; Chestnutt E; Gibson HS; Harris J; Keddie S; Millar JJ; Rozier J; Symons TL; Vargas-Ruiz C; Hay SI; Smith DL; Alonso PL; Noor AM; Bhatt S; Gething PW
    Lancet Infect Dis; 2021 Jan; 21(1):59-69. PubMed ID: 32971006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses to asexual blood-stages of malaria parasites.
    Yazdani SS; Mukherjee P; Chauhan VS; Chitnis CE
    Curr Mol Med; 2006 Mar; 6(2):187-203. PubMed ID: 16515510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children.
    Høgh B
    Scand J Infect Dis Suppl; 1996; 102():1-53. PubMed ID: 9060051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Childhood malaria in endemic areas: epidemiology, acquired immunity and control strategies].
    Rogier C
    Med Trop (Mars); 2003; 63(4-5):449-64. PubMed ID: 14763300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of malaria endemicity and tuberculosis prevalence on COVID-19 mortality.
    Raham TF
    Public Health; 2021 May; 194():33-35. PubMed ID: 33852995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-infection of malaria and early clearance of SARS-CoV-2 in healthcare workers.
    Mahajan NN; Gajbhiye RK; Bahirat S; Lokhande PD; Mathe A; Rathi S; Warty N; Mahajan KN; Srivastava V; Kuppusamy P; Mohite SC
    J Med Virol; 2021 Apr; 93(4):2431-2438. PubMed ID: 33368412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malaria Surveillance - United States, 2016.
    Mace KE; Arguin PM; Lucchi NW; Tan KR
    MMWR Surveill Summ; 2019 May; 68(5):1-35. PubMed ID: 31099769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Challenges and countermeasures on Chinese malaria elimination programme during the coronavirus disease 2019 (COVID-19) outbreak].
    Zhu GD; Cao J
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2020 Feb; 32(1):7-9. PubMed ID: 32185921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunity to SARS CoV-2 - strengths and weaknesses].
    Niehues T
    Dtsch Med Wochenschr; 2021 Dec; 146(24-25):1624-1635. PubMed ID: 34879413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against COVID-19 in African population: Immunology, genetics, and malaria clues for therapeutic targets.
    Altable M; de la Serna JM
    Virus Res; 2021 Jul; 299():198347. PubMed ID: 33631219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
    White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
    Front Immunol; 2021; 12():801799. PubMed ID: 35222355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.